𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response to paclitaxel in adenoid cystic carcinoma of the salivary glands

✍ Scribed by Brian G. Till; Renato G. Martins


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
140 KB
Volume
30
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background.

Paclitaxel is not considered to be an active drug in adenoid cystic carcinoma (ACC) of the salivary glands. We report 2 consecutive cases of patients with ACC who responded to paclitaxel.

Methods.

The patients were: (1) a 58‐year‐old man with recurrent ACC who developed pulmonary metastases, had progressive disease after a good response to first‐line chemotherapy, and then achieved a partial response to weekly single‐ agent paclitaxel; and (2) a 46‐year‐old woman with extensive thoracic ACC metastases who achieved a significant response after 2 cycles of paclitaxel chemotherapy.

Results.

The first patient died of progressive disease approximately 4 months after completing paclitaxel therapy, and the second patient had disease control after 6 cycles of paclitaxel.

Conclusions.

Systemic weekly paclitaxel produced a significant response in 2 patients with ACC of the head and neck, and its use in this disease merits further study. Β© 2007 Wiley Periodicals, Inc. Head Neck, 2008


πŸ“œ SIMILAR VOLUMES


Cytologic diagnosis of adenoid cystic ca
✍ Holger Nagel; Hermann Josef Hotze; Rainer Laskawi; Reinhard Chilla; Manfred Droe πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 637 KB

The cytomorphologic features in fine-needle aspiration (FNA) biopsies from 31 primary and 33 recurrent adenoid cystic carcinomas (ACC) were investigated. The correct FNA diagnosis was established in 24 of 31 primary ACC (77%). The diagnostic clue in aspirates from ACC are large globules of extracell

Immunohistochemical study of epidermal g
✍ Marilena Vered; Efraim Braunstein; Amos Buchner πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 1 views

## Background: Epidermal growth factor (egf) and its receptor (egfr) are involved in the development of salivary gland tumors. recently, treatment modalities for egfr inhibition have shown an enhanced clinical response in carcinomas of different locations. adenoid cystic carcinoma (acc) of salivary

Extracellular material in adenoid cystic
✍ Akihiko Kawahara; Hiroshi Harada; Masayoshi Kage; Toshiro Yokoyama; Masamichi Ko πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 215 KB πŸ‘ 1 views

The objective of this study was to clarify extracellular materials (ECMs) in adenoid cystic carcinoma (AdCC) and compare these to those found in other salivary gland tumors with myoepithelial differentiation. The ECM was examined with Papanicolaou, May-GrΓΌnwald-Giemsa (MGG), and alcian blue stain at

Adenoid cystic carcinoma of the esophagu
✍ Sigurdur R. Petursson πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 423 KB πŸ‘ 2 views

A 55-year-old man had adenoid cystic carcinoma of the esophagus metastatic to the lungs and right supraclavicular fossa. He was treated with local radiation therapy to the esophagus and supraclavicular fossa, followed by combination chemotherapy with doxorubicin, mitomycin C, and 5-fluorouracil(5-FU